课题基金 / 基金详情

Germline-Somatic Interactions and Association with Treatment Response in Cancer

Germline-Somatic Interactions and Association with Treatment Response in Cancer
种系-体细胞相互作用及其与癌症治疗反应的关联
批准号:
10702885
负责人:
Padma Rajagopal
金额:
$21.08万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Padma Rajagopal的其他基金

相似基金

相关文献

中文摘要
翻译
在文献中考察“生殖系-躯体相互作用”的研究在定义“生殖系”、“躯体”和“相互作用”方面有着戏剧性的异质性。然而,很少有研究直接评估人类数据,也几乎没有研究开始描述与这些“生殖系-躯体相互作用”相关的治疗反应。我们假设,我们将能够根据在特定的治疗环境中在原发乳腺癌和转移性乳腺癌中同时出现生殖系/体细胞突变来确定与治疗反应的不同关联。
英文摘要
Studies examining "germline-somatic interaction" in the literature have dramatic heterogeneity in defining "germline," "somatic," and "interaction." However, few studies have directly evaluated human data, and almost no studies have begun to characterize treatment response associated with these "germline-somatic interactions." We hypothesize that we will be able to identify differential associations with treatment response based on co-occurrence of germline / somatic mutations in specific settings of treatment in primary breast cancer and metastatic breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leveraging RNA and synthetic lethality in germline BRCA-mut breast cancer
  • 批准号:
    10926478
  • 项目类别:
  • 资助金额:
    $17.14万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
Germline-Somatic Interactions and Association with Treatment Response in Cancer
  • 批准号:
    10926516
  • 项目类别:
  • 资助金额:
    $8.57万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
Identifying synthetic lethal targets in metastatic triple negative breast cancer
  • 批准号:
    10487156
  • 项目类别:
  • 资助金额:
    $1.46万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
Identifying Treatment Options using RNA-Based Synthetic Lethality and Rescue
  • 批准号:
    10926479
  • 项目类别:
  • 资助金额:
    $17.14万
  • 财政年份:
    --
  • 负责人:
    Padma Rajagopal
  • 依托单位:
海外基金